QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)

Doximity (DOCS) Stock Forecast, Price & News

$20.99
+0.35 (+1.70%)
(As of 09/28/2023 ET)
Compare
Today's Range
$20.64
$21.25
50-Day Range
$19.86
$35.70
52-Week Range
$19.71
$40.12
Volume
1.77 million shs
Average Volume
1.96 million shs
Market Capitalization
$4.09 billion
P/E Ratio
38.16
Dividend Yield
N/A
Price Target
$29.50

Doximity MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
40.5% Upside
$29.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$786,781 Sold Last Quarter
Proj. Earnings Growth
18.33%
From $0.60 to $0.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.94 out of 5 stars

Medical Sector

77th out of 969 stocks

Custom Computer Programming Services Industry

4th out of 27 stocks


DOCS stock logo

About Doximity (NASDAQ:DOCS) Stock

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

DOCS Price History

DOCS Stock News Headlines

Reviewing Amdocs (NASDAQ:DOX) & Doximity (NASDAQ:DOCS)
Successful Options Trading Begins With…
Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!
Morgan Stanley Keeps Their Sell Rating on Doximity (DOCS)
Where Doximity Stands With Analysts
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Robert W. Baird Reaffirms Their Buy Rating on Doximity (DOCS)
Why Doximity Stock Took A Nosedive Today
Pre-market Movers: TYGO, BRSH, TNGX, VERI, DOCS…
Why Is Doximity (DOCS) Stock Down 23% Today?
Doximity Earnings: Too Many Problems, Sell
See More Headlines
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

DOCS Company Calendar

Last Earnings
8/08/2023
Today
9/28/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Custom computer programming services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DOCS
Fax
N/A
Employees
900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.50
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$21.00
Forecasted Upside/Downside
+39.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

Net Income
$112.82 million
Pretax Margin
33.23%

Debt

Sales & Book Value

Annual Sales
$419.05 million
Cash Flow
$0.77 per share
Book Value
$4.98 per share

Miscellaneous

Free Float
117,995,000
Market Cap
$4.13 billion
Optionable
Not Optionable
Beta
1.02
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Jeffrey A. Tangney (Age 50)
    Co-Founder, CEO & Chairperson
    Comp: $243.73k
  • Dr. Nate Gross M.D. (Age 39)
    Co-Founder & Chief Strategy Officer
    Comp: $455.54k
  • Ms. Anna BrysonMs. Anna Bryson (Age 33)
    Chief Financial Officer
    Comp: $453.71k
  • Ms. Jennifer W. Chaloemtiarana (Age 55)
    Gen. Counsel & Corp. Sec.
    Comp: $504.04k
  • Mr. Paul JorgensenMr. Paul Jorgensen (Age 52)
    Chief Revenue Officer
    Comp: $455.13k
  • Ms. Shari Buck
    Co-founder and SVP People & Ops
  • Mr. Jey Balachandran
    Chief Technology Officer
  • Mr. Perry Scott Gold
    Head of Investor Relations
  • Jim Rivas
    Head of Corp. Communications
  • Mr. Bruno Miranda
    Sr. VP of Engineering













DOCS Stock - Frequently Asked Questions

Should I buy or sell Doximity stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
View DOCS analyst ratings
or view top-rated stocks.

What is Doximity's stock price forecast for 2023?

10 brokerages have issued 1 year price objectives for Doximity's shares. Their DOCS share price forecasts range from $21.00 to $45.00. On average, they anticipate the company's stock price to reach $29.50 in the next year. This suggests a possible upside of 39.2% from the stock's current price.
View analysts price targets for DOCS
or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2023?

Doximity's stock was trading at $33.56 on January 1st, 2023. Since then, DOCS shares have decreased by 36.8% and is now trading at $21.20.
View the best growth stocks for 2023 here
.

When is Doximity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our DOCS earnings forecast
.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) issued its earnings results on Tuesday, August, 8th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.03. The company earned $108.47 million during the quarter, compared to analyst estimates of $106.98 million. Doximity had a trailing twelve-month return on equity of 13.11% and a net margin of 27.20%.

What guidance has Doximity issued on next quarter's earnings?

Doximity issued an update on its second quarter 2024 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $108.50 million-$109.50 million, compared to the consensus revenue estimate of $121.35 million.

When did Doximity IPO?

(DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

What is Doximity's stock symbol?

Doximity trades on the NASDAQ under the ticker symbol "DOCS."

Who are Doximity's major shareholders?

Doximity's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.49%), Clearbridge Investments LLC (3.45%), Baillie Gifford & Co. (3.39%), Eventide Asset Management LLC (2.00%), State Street Corp (1.63%) and Geode Capital Management LLC (1.08%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral.
View institutional ownership trends
.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Doximity's stock price today?

One share of DOCS stock can currently be purchased for approximately $21.20.

How much money does Doximity make?

Doximity (NASDAQ:DOCS) has a market capitalization of $4.13 billion and generates $419.05 million in revenue each year. The company earns $112.82 million in net income (profit) each year or $0.55 on an earnings per share basis.

How many employees does Doximity have?

The company employs 900 workers across the globe.

How can I contact Doximity?

The official website for the company is www.doximity.com. The company can be reached via phone at 650-549-4330 or via email at ir@doximity.com.

This page (NASDAQ:DOCS) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -